RxSight, Inc. (NasdaqGM: RXST)
Health Care · Health Care Equipment & Supplies · US
$6.40
+2.40% today · -27.4% 1Y
RxSight, Inc. (NasdaqGM: RXST) operates in the Health Care Equipment & Supplies industry within the Health Care sector. The company is valued at $259.96M and employs 461 people.
Over the last twelve months the share price has lost 27.4%, trading between 4.48 and 13.22.
Tweenvest scores RxSight, Inc. across four factors: quality 45/100, value 58/100, growth 100/100. Its strongest factor is growth.
RXST price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $259.96M
- Revenue (TTM)
- $127.58M
- P/E
- —
- EPS
- -1.14
- Dividend yield
- —
- Beta (5Y)
- 1.13
- 52-week high
- $13.22
- 52-week low
- $4.48
- Avg volume (3M)
- —
- Shares outstanding
- 41.59M
- Employees
- 461
- Next earnings
- —
About RxSight, Inc.
As a medical technology enterprise, RxSight, Inc. (which operated as Calhoun Vision, Inc. until its rebranding in February 2017) specializes in the innovation, manufacturing, and distribution of light-adjustable intraocular lenses (LALs). These advanced lenses are specifically designed for use in cataract surgery, serving patients in both domestic and international markets. The cornerstone of the company's offerings is the RxSight system, a sophisticated solution that enables ophthalmologists to precisely tailor and enhance a patient's visual acuity following cataract removal. An integral part of this system is the RxSight light delivery device, an in-office instrument. This device emits UV light in a carefully controlled pattern to modify the LAL, thereby ensuring optimal visual correction after the surgical procedure. RxSight's primary clientele consists of eye surgeons specializing in cataract treatments. The company was founded in 1997 and its corporate headquarters are situated in Aliso Viejo, California.
- ISIN
- US78349D1072
- Founded
- 1997
- Listed since
- Jul 30, 2021
- Exchange
- Nasdaq Global Market
- Currency
- USD
Other Health Care Equipment & Supplies companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Abbott LaboratoriesNYSE: ABT | $200.95B | $116.13 | -0.46% |
| Intuitive Surgical, Inc.NasdaqGS: ISRG | $131.36B | $371.84 | -0.46% |
| Stryker CorporationNYSE: SYK | $126.81B | $330.59 | +0.85% |
| Medtronic plcNYSE: MDT | $116.66B | $91.14 | -1.89% |
| EssilorLuxottica Société anonymeENXTPA: EL | $85.36B | €159.15 | -1.58% |
| Boston Scientific CorporationNYSE: BSX | $72.26B | $49.86 | +1.73% |
| HOYA CorporationTSE: 7741 | $52.49B | ¥24,995.00 | +0.40% |
| Edwards Lifesciences CorporationNYSE: EW | $52.38B | $90.87 | +0.41% |
Figures last refreshed Aug 18, 2026.